Upcoming Webinars: Materials

The Future of Drug-Delivery Devices


Drug-delivery devices not only provide a controlled and sustained release of therapeutic agents but also enable personalized medicine and targeted therapy. The continuous advancement of materials science, microfabrication techniques, wireless technology, and personalized medicine is driving the evolution of drug-delivery systems. This 60-minute Webinar from the editors of Medical Design Briefs examines the factors that determine the right delivery system.

Topics include:

  • The movement away from highly complex pump delivery systems toward less-expensive disposable models
  • The history and future of transdermals
  • How and why transdermals function
  • How patient-centric solutions could affect adherence
  • Exploring the advantages of a novel subcutaneous drug-delivery system

An audience Q&A session will follow the technical presentations.


Matthew J. Huddleston, Executive Vice President and Chief Technology Officer, Enable Injections

Matthew J. Huddleston serves as the Executive Vice President and Chief Technology Officer for Enable Injections. He is an experienced medical device professional with more than 20 years of experience in startup environments with emphasis in project management, design, development, manufacturing, regulatory, and intellectual property. Matt has several issued and pending patents in the medical device field including soft tissue and cardiovascular fixation devices and delivery instruments, histologic automated embedding systems, laparoscopic visualization devices, and automatic injection devices. He is a professional engineer and a licensed patent agent. Matt holds a bachelor’s degree in mechanical engineering from Purdue University and a master’s degree in biomedical engineering from The Ohio State University.

Peter van Beek, Business Development Manager, maxon

Peter van Beek heads up maxon’s Medical Business Unit in the USA as Business Development Manager. In this role, Peter is responsible for managing and promoting the maxon products used for the medical and dental device markets. He has been employed by maxon for more than 28 years and previously served as a Regional Sales Engineer, covering the Midwestern States, before taking on his current role. Peter holds a bachelor’s degree in mechanical engineering from the University of Wisconsin – Madison and a master’s degree in paper technology from Helsinki University of Technology.

Niraj Vasisht, Ph.D, Chief Technology Officer, Corium Innovations

Dr. Niraj Vasisht has 30 years of experience in the pharmaceutical industry and currently serves as the Chief Technology Officer at Corium Innovations. Previously, he was CEO of Avior Inc., leading the drug development to treat pruritus in liver-disease patients; was the CTO at Biodelivery Sciences, leading the company’s product development; and ran a CDMO business at Southwest Research, where he developed drug delivery technologies used today. Niraj has developed six commercial healthcare products sold in the U.S. and RoW markets and is a key opinion leader in microencapsulation and drug delivery. He is a book editor and has authored more than 30 patents and numerous publications. Niraj holds a doctorate in chemical engineering from Rensselaer Polytechnic Institute.


Amanda Hosey, Editor, SAE Media Group

By registering for this Webinar you agree to receive product announcements and special offers from SAE International via e-mail. By submitting your personal information, you agree that SAE Media Group, an SAE International Company, and carefully selected Partner Sponsors of this content may contact you and that you have read and agree to the Privacy Policy (CA Residents refer to Section D of the Privacy Policy). You may opt-out from communications at any time. You may reach us at This email address is being protected from spambots. You need JavaScript enabled to view it..